Connectus Wealth, LLC Laboratory Corp Of America Holdings Transaction History

Connectus Wealth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$197.69 - $227.29 $1,186 - $1,363	6 Added 0.31%	1,932 $439,000
Q3 2023 Nov 13, 2023	BUY	$201.05 - $221.7 $1,407 - $1,551	7 Added 0.36%	1,926 $387,000
Q2 2023 Aug 14, 2023	BUY	$211.93 - $241.33 $1,695 - $1,930	8 Added 0.42%	1,919 $463,000
Q1 2023 May 11, 2023	BUY	$213.32 - $257.83 $407,654 - $492,713	1,911 New	1,911 $438,000
Q3 2022 Nov 10, 2022	BUY	$204.81 - $262.19 $1,228 - $1,573	6 Added 0.3%	1,990 $408,000
Q2 2022 Aug 08, 2022	BUY	$213.86 - $277.87 $213 - $277	1 Added 0.05%	1,984 $465,000
Q1 2022 May 06, 2022	SELL	$259.82 - $298.18 $76,906 - $88,261	-296 Reduced 12.99%	1,983 $623,000
Q4 2021 Feb 09, 2022	BUY	$271.6 - $314.21 $618,976 - $716,084	2,279 New	2,279 $716,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Connectus Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Connectus Wealth, LLC with notifications on news.